PTC Therapeutics Authorizes $500 Million Share Repurchase Program
PTC Therapeutics’ board authorized a $500 million share repurchase program.
Related stories
BBVA Places CHF 290 Million Green Bond
BBVA placed CHF 290 million in a two-tranche senior preferred green bond issuance.
L impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
NexPoint Residential Trust Reports Quarterly Results
NexPoint Residential Trust reported results for the quarter ended September 30.
M impact | EQUITY | Nov 03, 2026, 03:27 PM UTC
Mazda North American October Sales Total 31,446 Vehicles
M impact | EQUITY | Nov 03, 2026, 03:26 PM UTC
Sysco CEO Says Restaurant Traffic and Operator Volume Softened in August
Sysco’s CEO said restaurant traffic and restaurant operator volume softened during August.
L impact | EQUITY | Nov 03, 2026, 03:26 PM UTC
Equita Group Board Approves €10 Million Tier 1 Note Issue
Equita Group’s board approved the issue of €10 million in additional Tier 1 notes.
M impact | EQUITY | Nov 03, 2026, 03:25 PM UTC
Galata Wind Q3 revenue falls to 868.6 million lira
Q3 revenue was 868.6 million lira, versus 1.2 billion lira a year earlier.
M impact | EQUITY | Nov 03, 2026, 03:25 PM UTC